Literature DB >> 12050335

Sirolimus-eluting coronary stents.

Gregory D Curfman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12050335     DOI： 10.1056/NEJM200206063462302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.

Authors:  Yong-Dan Tang; Ambarish Pandey; Antonina Kolmakova; Xin-Tong Wang; Subbu S Venkatraman; Subroto Chatterjee; Freddy Y C Boey
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

2.  Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Claudia Clavijo; Tobin Strom; Vanessa Moll; Ronald Betts; Yan Ling Zhang; Uwe Christians; Jamie Bendrick-Peart
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-08-21       Impact factor: 3.205

3.  Endovascular therapy for acute thrombotic occlusion of the intracranial artery.

Authors:  Tomoyuki Tsumoto; Tomoaki Terada; Mitsuharu Tsuura; Yukiaki Ryujin; Hiroyuki Matsumoto; Osamu Masuo; Hiroo Yamaga; Toru Itakura
Journal:  Neuroradiology       Date:  2004-05-13       Impact factor: 2.804

Review 4.  Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries.

Authors:  Isabel Preeshagul; Rajendra Gharbaran; Kyung Hwa Jeong; Ahmed Abdel-Razek; Leonard Y Lee; Elie Elman; K Stephen Suh
Journal:  J Cardiothorac Surg       Date:  2013-07-18       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.